LY9 and diabetes mellitus: SLAMF3 plays a role in diabetes in such a way that palmitic acid activates SLAMF3 on human T cells through the STAT5-PI3K/Akt pathway, exhibiting the chronic inflammatory characteristics of type 2 diabetes (98).